Nanobiotix (NBTX) Short Interest Ratio & Short Volume → America’s worst nightmare? (From Porter & Company) (Ad) Free NBTX Stock Alerts $7.29 +0.44 (+6.42%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Nanobiotix Short Interest DataCurrent Short Volume55,700 sharesPrevious Short Volume52,700 sharesChange Vs. Previous Month+5.69%Dollar Volume Sold Short$325,288.00Short Interest Ratio / Days to Cover1.5Last Record DateApril 30, 2024Outstanding Shares47,130,000 sharesPercentage of Shares Shorted0.12%Today's Trading Volume6,168 sharesAverage Trading Volume30,254 sharesToday's Volume Vs. Average20% Short Selling Nanobiotix ? Sign up to receive the latest short interest report for Nanobiotix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNBTX Short Interest Over TimeNBTX Days to Cover Over TimeNBTX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingTrump’s Former Wingman Bets Big on AIOne of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here. Nanobiotix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202455,700 shares $325,288.00 +5.7%N/A1.5 $5.84 4/15/202452,700 shares $294,593.00 +4.8%N/A1.5 $5.59 3/31/202450,300 shares $326,944.97 +4.1%N/A2.6 $6.50 3/15/202448,300 shares $335,685.00 +12.1%N/A3.8 $6.95 2/29/202443,100 shares $269,375.00 +0.2%N/A2.3 $6.25 2/15/202443,000 shares $317,340.00 +2.4%N/A2.3 $7.38 Get the Latest News and Ratings for NBTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter. 1/31/202442,000 shares $319,200.00 -7.9%N/A2.2 $7.60 1/15/202445,600 shares $357,960.00 +27.7%N/A2.3 $7.85 12/31/202335,700 shares $259,896.00 +113.8%N/A1.9 $7.28 12/15/202316,700 shares $104,208.00 +138.6%N/A0.9 $6.24 11/30/20237,000 shares $39,235.00 -23.1%N/A0.6 $5.61 11/15/20239,100 shares $53,144.00 -24.8%N/A0.4 $5.84 10/31/202312,100 shares $79,255.00 -36.7%N/A0.3 $6.55 10/15/202319,100 shares $127,970.00 +6.1%N/A0.4 $6.70 9/30/202318,000 shares $157,500.00 -4.3%N/A0.2 $8.75 9/15/202318,800 shares $177,039.60 -21.3%0.1%0.1 $9.42 8/31/202323,900 shares $218,446.00 -15.6%0.1%0.1 $9.14 8/15/202328,300 shares $234,041.00 -38.9%0.1%0.1 $8.27 7/31/202346,300 shares $356,973.00 -62.2%0.1%0.2 $7.71 7/15/2023122,400 shares $779,688.00 +367.2%0.4%0.1 $6.37 6/30/202326,200 shares $135,716.00 -22.0%0.1%0 $5.18 6/15/202333,600 shares $172,368.00 -8.5%0.1%0 $5.13 5/31/202336,700 shares $168,086.00 -49.9%0.1%0.1 $4.58 5/15/202373,200 shares $343,308.00 +850.7%0.2%0.1 $4.69 4/30/20237,700 shares $16,478.00 +28.3%0.0%0 $2.14 4/15/20236,000 shares $23,700.00 -22.1%0.0%3.5 $3.95 3/31/20237,700 shares $27,142.50 +30.5%0.0%5.9 $3.53 3/15/20235,900 shares $20,467.69 No Change0.0%4.2 $3.47 2/28/20235,900 shares $20,768.00 +391.7%0.0%4.2 $3.52 2/15/20231,200 shares $4,428.00 -33.3%N/A0.8 $3.69 1/31/20231,800 shares $7,686.00 +50.0%0.0%1.3 $4.27 1/15/20231,200 shares $5,136.84 -55.6%N/A1 $4.28 12/30/20222,700 shares $9,909.00 +42.1%0.0%1.6 $3.67 12/15/20221,900 shares $7,600.00 -9.5%0.0%1 $4.00 11/30/20222,100 shares $8,295.00 -25.0%0.0%1.1 $3.95 11/15/20222,800 shares $11,634.00 +40.0%0.0%1.3 $4.16 10/31/20222,000 shares $7,920.00 -64.9%0.0%0.9 $3.96 10/15/20225,700 shares $20,007.00 -52.1%0.0%1.7 $3.51 9/30/202211,900 shares $42,126.00 +30.8%0.0%4.1 $3.54 9/15/20229,100 shares $38,675.00 +116.7%0.0%3.5 $4.25The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. NBTX Short Interest - Frequently Asked Questions What is Nanobiotix's current short interest? Short interest is the volume of Nanobiotix shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 55,700 shares of NBTX short. Learn More on Nanobiotix's current short interest. What is a good short interest ratio for Nanobiotix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NBTX shares currently have a short interest ratio of 2.0. Learn More on Nanobiotix's short interest ratio. Is Nanobiotix's short interest increasing or decreasing? Nanobiotix saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 55,700 shares, an increase of 5.7% from the previous total of 52,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Nanobiotix's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nanobiotix: Precigen, Inc. (11.81%), Atea Pharmaceuticals, Inc. (2.43%), Verastem, Inc. (3.49%), AC Immune SA (0.88%), ADC Therapeutics SA (1.43%), Kamada Ltd. (0.12%), Nkarta, Inc. (14.02%), Nektar Therapeutics (1.99%), Revance Therapeutics, Inc. (11.77%), Erasca, Inc. (10.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Nanobiotix stock? Short selling NBTX is an investing strategy that aims to generate trading profit from Nanobiotix as its price is falling. NBTX shares are trading up $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nanobiotix? A short squeeze for Nanobiotix occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NBTX, which in turn drives the price of the stock up even further. How often is Nanobiotix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NBTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Precigen Short Interest Data Atea Pharmaceuticals Short Interest Data Verastem Short Interest Data AC Immune Short Interest Data ADC Therapeutics Short Interest Data Kamada Short Interest Data Nkarta Short Interest Data Nektar Therapeutics Short Interest Data Revance Therapeutics Short Interest Data Erasca Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NBTX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper